The treatment of neuropathic pain: antidepressants and opioids.
about
Tramadol for neuropathic painTramadol for neuropathic painClinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressantsAmitriptyline is a TrkA and TrkB receptor agonist that promotes TrkA/TrkB heterodimerization and has potent neurotrophic activityChemokines and the pathophysiology of neuropathic painIdentification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain.Mechanisms of pain.A2delta ligands gabapentin and pregabalin: future implications in daily clinical practice.Antidepressants in the management of cancer pain.Current aproach to cancer pain management: Availability and implications of different treatment options.The pathogenesis and management of painful diabetic neuropathy: a review.New treatments for diabetic neuropathy: symptomatic treatments.Systematic overview of the pharmacological management of postherpetic neuralgia. An evaluation of the clinical value of critically selected drug treatments based on efficacy and safety outcomes from randomized controlled studies.Melatonin in antinociception: its therapeutic applications.Clinical management of pain in advanced lung cancer.Amitriptyline 2% cream vs. capsaicin 0.75% cream in the treatment of painful diabetic neuropathy (Double blind, randomized clinical trial of efficacy and safety)Efficacy of pregabalin and gabapentin for neuropathic pain in spinal-cord injury: an evidence-based evaluation of the literature.Cytokine and chemokine regulation of sensory neuron function.Assessing the appropriateness of pain medication prescribing practices in nursing homes.Transforming growth factor-beta1 impairs neuropathic pain through pleiotropic effects.Neuropathic pain and the endocannabinoid system in the dorsal raphe: pharmacological treatment and interactions with the serotonergic system.Effects of paroxetine and sertraline on low-density lipoprotein cholesterol: an observational cohort study.Pharmacological and behavioral characterization of the saphenous chronic constriction injury model of neuropathic pain in rats.The effect of nitric oxide synthase inhibitors on the development of analgesic tolerance to dipyrone in mice.Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.Enriched environment prevents hypobaric hypoxia induced neurodegeneration and is independent of antioxidant signaling.Polyneuropathy with Impaired Glucose Tolerance: Implications for Diagnosis and Therapy.Analgesics and AntipyreticsTreatment of chronic pain in children and adolescents
P2860
Q24245564-35921D64-E238-45F7-BBB1-D4546A81C1CCQ24247159-DAF1FAA6-F322-487B-B396-D5930BB238BBQ24610169-42E6DACA-BD45-441F-A0EB-3A7784DE268EQ24615575-042679CC-3973-4C69-A8F1-D21E5D7D0708Q24683873-5EF765F4-A40F-46C3-AD48-3F9712523E69Q31076606-AE0D73F3-00CF-473A-9859-FF5169A474C3Q33946821-D9707B90-8244-421D-8ABE-889D712CEF6EQ33953965-3E4BD4A4-A581-4E9A-9803-FB96F42CA7A0Q34222796-72B5E745-708F-4513-9216-0D81836A4CE8Q34779398-E8ED9021-2069-476D-B6BE-0B08FAD8D90BQ35064423-8633BE46-3BAD-46D6-8A96-1E16432AA666Q35581287-F307CD06-5454-4700-90DD-441B418A4E34Q35760514-A28746B3-B3CF-4A60-94B0-6337F520EA76Q36067329-CF260F63-EF19-4868-BA39-C0F77C28246CQ36327481-EBE9EEE4-9C57-4FFF-A0C2-BF3D4D99938FQ36358428-059CAE99-991E-49A9-8B76-6AB2B3EEDA9FQ37209577-73DF37F8-22A1-41BF-A0B6-CDDD19ECFC58Q37351994-3F0EAC7A-9B90-4438-A72B-F6A60EC0D609Q39744667-C4ADF1FA-D9A7-460A-BA49-099500435A7CQ41892208-966F3B31-94CB-4752-9BC4-B1FB135E29EEQ42502701-901A37F0-992E-4399-99B2-739F4E734E71Q43279219-19B77A98-8A7F-4A64-BFC8-E3530D014160Q44519724-A3037DE9-0EB5-486F-88A5-10280DA605EDQ46072178-18DEDC2E-D5A3-47F2-BB37-98BE5F8DE542Q46091944-8D86D724-1A38-49C1-B818-4FFC616B3C43Q48661748-A05E9DFA-9FB6-4E64-843F-8ECF3BBF0C03Q51524725-CF5FE12C-1E0D-49E3-A0F9-018D5962B130Q56113559-034C4B89-20C9-45C0-B2CD-812D72108C7BQ57821765-E1646BE9-BA8A-426F-A908-E99A0B795C43
P2860
The treatment of neuropathic pain: antidepressants and opioids.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The treatment of neuropathic pain: antidepressants and opioids.
@ast
The treatment of neuropathic pain: antidepressants and opioids.
@en
type
label
The treatment of neuropathic pain: antidepressants and opioids.
@ast
The treatment of neuropathic pain: antidepressants and opioids.
@en
prefLabel
The treatment of neuropathic pain: antidepressants and opioids.
@ast
The treatment of neuropathic pain: antidepressants and opioids.
@en
P1476
The treatment of neuropathic pain: antidepressants and opioids.
@en
P2093
P304
P356
10.1097/00002508-200006001-00009
P407
P433
P577
2000-06-01T00:00:00Z